FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix’s investigational intranasal potentiated oxytocin ...

Codi today announced the launch of its groundbreaking AI Office Manager, the first-ever AI-powered platform designed to fully automate the operational complexities of physical office spaces. The ...

In our journey through academia, contract research organizations, big pharma and biotech startups, we have had the ...

Type 2 diabetes is surging in children, now making up 24% to 45% of youth diabetes cases – up from just 1% to 2% before the ...

Type 2 diabetes (T2D), once considered an adult-onset disease, is increasing at alarming rates in children and adolescents. Before the mid-1990s, just ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

LISCure BioSciences ("LISCure") announced that its proprietary joint health probiotic, JointWorks®, has been officially approved by the Korean Ministry of Food and Drug Safety (MFDS) as Recognized ...

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.